focus -WSS

focus

author：hotspot 2025-09-29 01:46:21 - browse：8

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

The new medicine, called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics. Its authorization is a scientific triumph for the technology that can efficiently and precisely repair DNA mutations — ushering in a new era of genetic medicines for inherited diseases.

In a clinical trial, Casgevy was shown to eliminate recurrent episodes of debilitating pain caused by sickle cell, which afflicts approximately 100,000 people in the U.S., a vast majority of whom are Black. The therapy, whose scientific name is exa-cel, is described as a potential cure because the genetic fix enabled by CRISPR is designed to last a lifetime, although confirmation will require years of follow-up.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Key Senate committee drafts bipartisan bill to stem drug shortages

WSS

Dogs on Prozac: What pet anti

MassMutual is introducing free genetic testing for members

PrEP can help anyone prevent HIV. Why do so few people take it?

FTC falls short on scrutinizing hospital mergers, study says

UnitedHealth financials solid despite Change Healthcare cyberattack

Why rehabilitation engineers need to center patients in their research

knowledge

focus

focus

Medicare details structure of new drug price negotiation program

Cancer researcher Catriona Jamieson is sending tumors into space

Hepatitis C has a cure — but many Americans still lack access to it

Cue Health's Covid

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What Henrietta Lacks's story taught me about my role as a doctor

In Memoriam: Notable people who died in 2023

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Medical leaders decry Supreme Court decision on affirmative action

4 missing after record

leisure time

Cell therapy fails to slow type 1 diabetes, but safety is established

My chronic pain journey would have been easier knowing 5 things % STAT

Diversity in clinical trials starts with building trust, experts say

The response to Covid

Bird flu outbreak in cows is latest avian flu curveball

Diversity in clinical trials starts with building trust, experts say

focus

Wikipedia

entertainment

hotspot